vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是COLLEGIUM PHARMACEUTICAL, INC的1.0倍（$212.2M vs $205.4M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 8.3%，领先10.5%），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 8.6%），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs 11.1%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
COLL vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.0倍
$205.4M
营收增速更快
COLL
高出4.3%
8.6%
净利率更高
RAMP
高出10.5%
8.3%
两年增速更快
COLL
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $212.2M |
| 净利润 | $17.0M | $39.9M |
| 毛利率 | 62.5% | 71.9% |
| 营业利润率 | 29.6% | 18.6% |
| 净利率 | 8.3% | 18.8% |
| 营收同比 | 12.9% | 8.6% |
| 净利润同比 | 35.3% | 255.7% |
| 每股收益（稀释后） | $0.48 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COLLRAMP
| Q4 25 | $205.4M | $212.2M | ||
| Q3 25 | $209.4M | $199.8M | ||
| Q2 25 | $188.0M | $194.8M | ||
| Q1 25 | $177.8M | $188.7M | ||
| Q4 24 | $181.9M | $195.4M | ||
| Q3 24 | $159.3M | $185.5M | ||
| Q2 24 | $145.3M | $176.0M | ||
| Q1 24 | $144.9M | $171.9M |
净利润COLLRAMP
| Q4 25 | $17.0M | $39.9M | ||
| Q3 25 | $31.5M | $27.4M | ||
| Q2 25 | $12.0M | $7.7M | ||
| Q1 25 | $2.4M | $-6.3M | ||
| Q4 24 | $12.5M | $11.2M | ||
| Q3 24 | $9.3M | $1.7M | ||
| Q2 24 | $19.6M | $-7.5M | ||
| Q1 24 | $27.7M | $-5.4M |
毛利率COLLRAMP
| Q4 25 | 62.5% | 71.9% | ||
| Q3 25 | 61.7% | 70.2% | ||
| Q2 25 | 57.7% | 70.1% | ||
| Q1 25 | 54.8% | 69.3% | ||
| Q4 24 | 54.0% | 71.9% | ||
| Q3 24 | 60.8% | 72.4% | ||
| Q2 24 | 62.5% | 70.6% | ||
| Q1 24 | 63.1% | 72.2% |
营业利润率COLLRAMP
| Q4 25 | 29.6% | 18.6% | ||
| Q3 25 | 29.7% | 10.7% | ||
| Q2 25 | 18.7% | 3.7% | ||
| Q1 25 | 12.2% | -6.1% | ||
| Q4 24 | 20.9% | 7.5% | ||
| Q3 24 | 21.9% | 4.0% | ||
| Q2 24 | 32.7% | -3.0% | ||
| Q1 24 | 34.1% | -8.3% |
净利率COLLRAMP
| Q4 25 | 8.3% | 18.8% | ||
| Q3 25 | 15.0% | 13.7% | ||
| Q2 25 | 6.4% | 4.0% | ||
| Q1 25 | 1.4% | -3.3% | ||
| Q4 24 | 6.9% | 5.7% | ||
| Q3 24 | 5.9% | 0.9% | ||
| Q2 24 | 13.5% | -4.3% | ||
| Q1 24 | 19.1% | -3.1% |
每股收益（稀释后）COLLRAMP
| Q4 25 | $0.48 | $0.62 | ||
| Q3 25 | $0.84 | $0.42 | ||
| Q2 25 | $0.34 | $0.12 | ||
| Q1 25 | $0.07 | $-0.10 | ||
| Q4 24 | $0.36 | $0.17 | ||
| Q3 24 | $0.27 | $0.03 | ||
| Q2 24 | $0.52 | $-0.11 | ||
| Q1 24 | $0.71 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.7M | $962.3M |
| 总资产 | $1.7B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COLLRAMP
| Q4 25 | $386.7M | $403.4M | ||
| Q3 25 | $285.9M | $376.9M | ||
| Q2 25 | $222.2M | $371.1M | ||
| Q1 25 | $197.8M | $420.8M | ||
| Q4 24 | $162.8M | $384.3M | ||
| Q3 24 | $120.0M | $348.4M | ||
| Q2 24 | $271.6M | $342.7M | ||
| Q1 24 | $318.0M | $368.9M |
股东权益COLLRAMP
| Q4 25 | $301.7M | $962.3M | ||
| Q3 25 | $274.8M | $943.8M | ||
| Q2 25 | $232.2M | $947.8M | ||
| Q1 25 | $234.4M | $948.9M | ||
| Q4 24 | $228.8M | $957.7M | ||
| Q3 24 | $234.3M | $932.1M | ||
| Q2 24 | $216.6M | $951.9M | ||
| Q1 24 | $222.2M | $949.1M |
总资产COLLRAMP
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | — |
| 自由现金流经营现金流 - 资本支出 | $122.4M | — |
| 自由现金流率自由现金流/营收 | 59.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | 0.1% |
| 现金转化率经营现金流/净利润 | 7.25× | — |
| 过去12个月自由现金流最近4个季度 | $327.6M | — |
8季度趋势，按日历期对齐
经营现金流COLLRAMP
| Q4 25 | $123.0M | — | ||
| Q3 25 | $78.4M | $57.4M | ||
| Q2 25 | $72.4M | $-15.8M | ||
| Q1 25 | $55.4M | — | ||
| Q4 24 | $84.6M | $45.1M | ||
| Q3 24 | $-9.0M | $55.6M | ||
| Q2 24 | $67.4M | $-9.3M | ||
| Q1 24 | $61.9M | — |
自由现金流COLLRAMP
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | $56.8M | ||
| Q2 25 | $72.4M | $-16.2M | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | $44.8M | ||
| Q3 24 | $-9.2M | $55.4M | ||
| Q2 24 | $67.1M | $-9.6M | ||
| Q1 24 | $61.4M | — |
自由现金流率COLLRAMP
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | 28.4% | ||
| Q2 25 | 38.5% | -8.3% | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | 22.9% | ||
| Q3 24 | -5.8% | 29.8% | ||
| Q2 24 | 46.2% | -5.4% | ||
| Q1 24 | 42.3% | — |
资本支出强度COLLRAMP
| Q4 25 | 0.3% | 0.1% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.4% | 0.2% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 0.2% | 0.1% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 0.4% | 1.0% |
现金转化率COLLRAMP
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | 2.09× | ||
| Q2 25 | 6.05× | -2.04× | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | 4.02× | ||
| Q3 24 | -0.96× | 32.10× | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
